Table 2.

New miRNAs located in regions amplified in breast cancer as detected by BAC array CGH

IDCytobandHost geneLuminal ALuminal BERBB2BasalNormal-likeUnclassifiedER+ERBRCA1BRCA2Total
Candidate_111p12PHGDH00030002631
hsa-mir-31211q25.3ACBD610610003601
hsa-mir-36822p16.2LOC10030265200030002601
hsa-mir-47782p1400010001600
hsa-mir-46355p15.33SLC12A701010001601
hsa-mir-44698p11.21RNF17016000021031
hsa-mir-46618q21.3LRRC6904030213062
hsa-mir-3150b8q22.1093302240103
hsa-mir-3150a8q22.1093302240103
hsa-mir-44718q22.2076502340103
Candidate_1638q22.3PABPC1096502350104
Candidate_1648q24.13DERL11130904640165
hsa-mir-46638q24.131130904640165
hsa-mir-4662b8q24.131163809750166
hsa-mir-4662a8q24.131163809750166
hsa-mir-46659p24.1KIAA202600030001601
hsa-mir-468310p11.21FZD800030002601
hsa-mir-469111q13.2NDUFS806000020001
Candidate_21311q13.3IGHMBP2111016043003
hsa-mir-366411q13.4SHANK2110013242003
hsa-mir-3913-112q1507003030032
hsa-mir-472317q11.2TMEM199001230213002
hsa-mir-451b17q11.2002440226003
hsa-mir-473217q11.2002440226003
hsa-mir-473417q12043213439035
hsa-mir-472617q12MLLT61438334411036
hsa-mir-472717q121438334411036
Candidate_29617q12LASP11444434413037
hsa-mir-472817q12ERBB22785915682701014
hsa-mir-361417q23.2TRIM25131510425033
hsa-mir-473617q23.2031210214032
hsa-mir-472917q23.2YPEL2041230024033
hsa-mir-473717q23.2041510426033
hsa-mir-306417q24.1DDX503900213002
hsa-mir-452417q24.3ABCA600900002001
Candidate_29917q25.1KIAA019501910213002
hsa-mir-473817q25.101610213001
hsa-mir-306517q25.304300011031
hsa-mir-319420q13.2NFATC204000010001
Total sample number9570347934472271191731359

NOTE: High-level gains were identified in a set of 359 tumors classified according to subtype (luminal A, luminal B, ERBB2-positive, basal, and normal-like), ER expression and BRCA1 and BRCA2 mutation status. Shown are the percentages of tumors with gains within each subgroup.